An attempt to independently verify the utility of the Van Nuys Prognostic Index for ductal carcinoma in situ

Cancer

Volumn 110, Issue 12, 2007, Pages 2648-2653

  MacAusland, Stephanie G ^a   Hepel, Jaroslaw T ^b   Chong, Frank K ^c   Galper, Shira L ^b   Gass, Jennifer S ^d   Ruthazer, Robin ^e   Wazer, David E ^a,b  

^a BROWN UNIVERSITY   (United States)

^b TUFTS MEDICAL CENTER   (United States)

^c ST ELIZABETH'S MEDICAL CENTER   (United States)

^d WOMEN AND INFANTS HOSPITAL   (United States)

^e TUFTS UNIVERSITY   (United States)

Author keywords

Breast cancer; Ductal carcinoma in situ; Margins; Radiotherapy; Van Nuys Prognostic Index

Indexed keywords

TAMOXIFEN;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL ASSESSMENT; CONTROLLED STUDY; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; TUMOR BIOPSY; TUMOR VOLUME;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; FEMALE; HEALTH STATUS INDICATORS; HUMANS; MASTECTOMY; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 37049003817     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23089     Document Type: Article

References (20)

1. Ernster VL, Barclay J, Kerlikowske K, Grady D, Henderson CI. Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA. 1996;275:913-918.
2. VanDongen JA, Holland R, Peterse JL, et al. Ductal carcinoma in situ of the breast: second EORTC consensus meeting. Eur J Cancer. 1992;28:626-629.
3. Lagios MD, Margolin FR, Westdahl PR, Rose MR. Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer. 1989;63:618-624.
4. Silverstein MJ, Waisman JR, Gamagami P, et al. Intraductal carcinoma of the breast (208 cases). Clinical factors influ-encing treatment choice. Cancer. 1990;66:102-108.
5. Solin LJ, Yeh IT, Kurtz J, et al. Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with breast-conserving surgery and definitive irradiation. Correlation of pathologic parameters with outcome of treatment. Cancer. 1993;71:2532-2542.
6. Gage I, Schnitt SJ, Nixon AJ, et al. Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving surgery. Cancer. 1996;78:1921-1928.
7. Sneige N, McNeese MD, Atkinson EN, et al. Ductal carcinoma in situ treated with lumpectomy and irradiation: histopathological analysis of 49 specimens with emphasis on risk factors and long term results. Hum Pathol. 1995;26:642-649.
8. Wazer DE, Schmidt-Ullrich RK, Ruthazer R, et al. Factors determining outcome for breast-conserving irradiation with margin-directed dose escalation to the tumor bed. Int J Radiat Oncol Biol Phys. 1998;40:851-858.
9. Van Zee KJ, Liberman L, Samli B, et al. Long term follow-up of women with ductal carcinoma in situ treated with breast-conserving surgery: the effect of age. Cancer. 1999;86:1757-1767.
10. Vicini FA, Kestin LL, Goldstein NS, et al. Impact of young age on outcome in patients with ductal carcinoma-in-situ treated with breast conserving therapy. J Clin Oncol. 2000;18:296-306.
11. Silverstein MJ, Lagios MD, Craig PH, et al. A prognostic index for ductal carcinoma in situ of the breast. Cancer 1996;77:2267-2274.
12. Silverstein MJ. The University of Southern California/Van Nuys prognostic index for ductal carcinoma in situ of the breast. Am J Surg. 2003;186:337-343.
13. Silverstein MJ, Lagios MD, Groshen S, et al. The influence of margin width on local control of ductal carcinoma in situ of the breast. N Engl J Med. 1999;340:1455-1461.
14. Wong JS, Kaelin CM, Troyan SL, et al. Prospective study of wide excision alone for ductal carcinoma in situ of the breast. J Clin Oncol. 2006;24:1031-1036.
15. Mascarel I, Bonichon F, MacGrogan G, et al. Application of the Van Nuys prognostic index in a retrospective series of 367 ductal carcinomas in situ of the breast examined by serial macroscopic sectioning: practical considerations. Breast Cancer Res Treat. 2000;61:151-159.
16. Boland GP, Chan KC, Konx WF, Roberts SA, Bundred NJ. Value of the Van Nuys prognostic index in prediction of recurrence of ductal carcinoma in situ after breast-conserving surgery. Br J Surg. 2003;90:426-432.
17. Shoker BS, Sloane JP. DCIS grading schemes and clinical implications. Histopathology. 1999;35:393-400.
18. Silverstein MJ, Poller DN, Waisman JR, et al. Prognostic classification of breast ductal carcinoma-in-situ. Lancet. 1995;345:1154-1157.
19. Fisher B, Land S, Mamounas E, Dignam J, Fisher ER, Wolmark N. Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience. Semin Oncol. 2001;28:400-418.
20. Bijker N, Meijnen P, Peterse JL, et al. Breast-conserving treatment with or without radiotherapy in ductal carcinoma in situ: ten-year results of European Organization for Research and Treatment of Cancer randomized phase III Trial 10853 - a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol. 2006;24:3381-3387.